Kura Oncology Inc (KURA)

R&D Expense Growth

47.72%

Fiscal year · Period ending:

KURA logo

KURA R&D Expense Growth

Latest reported47.72%
KURA FY R&D Growth (YoY) (0.00% → 47.72%)
High-resolution chart · PNG

KURA r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Kura Oncology Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
47.7193%
47.496%
24.1596%
9.5502%
40.2735%
26.2849%
2.2207%
77.0491%
29.5138%
14.7775%
120.9421%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.